Coronavirus Update: Synairgen Tests First Inhaled Candidate, No New China Cases
While Survey Shows Looming Crisis In Trial Recruitment
More studies are being launched into possible treatments for patients hospitalised with COVID-19, with Roche launching a Phase III, placebo-controlled trial of Actemra.